AHRQ Patient Safety Network: Residual anaesthesia drugs in intravenous lines—a silent threat?

AHRQ Patient Safety Network



Residual anaesthesia drugs in intravenous lines—a silent threat?

Bowman S, Raghavan K, Walker IA. Anaesthesia. 2013;68:557-561.

This commentary examines how residual medications in intravenous lines can harm patients and emphasizes the need for these incidents to be reported.

PubMed citation 
Available at  

Related Resources

STUDY

The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: a report from the Pediatric Sedation Research Consortium.

Cravero JP, Beach ML, Blike GT, Gallagher SM, Hertzog J; Pediatric Sedation Research Consortium. Anesth Analg. 2009;108:795-804.

NEWSPAPER/MAGAZINE ARTICLE

Administering a saline flush "site unseen" can lead to a wrong route error.

ISMP Medication Safety Alert! Acute Care Edition. May 16, 2013;18:1-3.

REVIEW

Quality and safety in pediatric anesthesia: how can guidelines, checklists, and initiatives improve the outcome?

Hagerman NS, Varughese AM, Kurth CD. Curr Opin Anaesthesiol. 2014;27:323-329.

COMMENTARY

No BP During NIBP

Matthias Görges, PhD, and J. Mark Ansermino, MBBCh, MSc AHRQ WEBMM [serial online]. September 2014

View all related resources...